FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 96 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $81,732,000 | +132.0% | 2,169,678 | +4.8% | 0.00% | +100.0% |
| Q4 2020 | $35,223,000 | +390.9% | 2,070,727 | +35.6% | 0.00% | – |
| Q3 2020 | $7,175,000 | -23.7% | 1,526,650 | -1.0% | 0.00% | – |
| Q2 2020 | $9,404,000 | +158.4% | 1,541,686 | -3.8% | 0.00% | – |
| Q1 2020 | $3,639,000 | -50.3% | 1,603,230 | +0.5% | 0.00% | – |
| Q4 2019 | $7,323,000 | +16.5% | 1,595,459 | -1.6% | 0.00% | – |
| Q3 2019 | $6,284,000 | -33.6% | 1,621,566 | +3.3% | 0.00% | – |
| Q2 2019 | $9,466,000 | -64.7% | 1,569,821 | -21.4% | 0.00% | -100.0% |
| Q1 2019 | $26,778,000 | +113.6% | 1,998,409 | +48.2% | 0.00% | 0.0% |
| Q4 2018 | $12,536,000 | -60.0% | 1,348,010 | -40.1% | 0.00% | 0.0% |
| Q3 2018 | $31,344,000 | -9.3% | 2,251,778 | +3.0% | 0.00% | 0.0% |
| Q2 2018 | $34,550,000 | -4.9% | 2,185,293 | +3.3% | 0.00% | -50.0% |
| Q1 2018 | $36,347,000 | -8.4% | 2,115,651 | +16.9% | 0.00% | 0.0% |
| Q4 2017 | $39,663,000 | -44.4% | 1,809,454 | +3.8% | 0.00% | -33.3% |
| Q3 2017 | $71,293,000 | +43.2% | 1,742,704 | +5.4% | 0.00% | +50.0% |
| Q2 2017 | $49,800,000 | -16.8% | 1,653,937 | -0.1% | 0.00% | -33.3% |
| Q1 2017 | $59,864,000 | -45.3% | 1,655,985 | -24.1% | 0.00% | -50.0% |
| Q4 2016 | $109,382,000 | +21.0% | 2,182,845 | +26.7% | 0.01% | +20.0% |
| Q3 2016 | $90,432,000 | +48.5% | 1,722,827 | +17.0% | 0.01% | +25.0% |
| Q2 2016 | $60,877,000 | +46.0% | 1,472,276 | +43.5% | 0.00% | +33.3% |
| Q1 2016 | $41,684,000 | +21.7% | 1,025,965 | +24.3% | 0.00% | +50.0% |
| Q4 2015 | $34,262,000 | -78.8% | 825,592 | -85.3% | 0.00% | -66.7% |
| Q3 2015 | $161,951,000 | +1036.3% | 5,597,500 | +875.5% | 0.01% | +500.0% |
| Q2 2015 | $14,253,000 | +17.8% | 573,805 | +8.3% | 0.00% | 0.0% |
| Q1 2015 | $12,104,000 | +43.9% | 529,717 | +70.1% | 0.00% | 0.0% |
| Q4 2014 | $8,410,000 | +134.3% | 311,479 | +1.8% | 0.00% | – |
| Q3 2014 | $3,589,000 | -6.9% | 305,907 | +23.4% | 0.00% | – |
| Q2 2014 | $3,856,000 | -15.3% | 247,977 | +7.0% | 0.00% | – |
| Q1 2014 | $4,555,000 | +585.0% | 231,651 | +485.0% | 0.00% | – |
| Q4 2013 | $665,000 | – | 39,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,381,117 | $47,065,000 | 4.14% |
| GREAT POINT PARTNERS LLC | 1,647,753 | $22,937,000 | 3.58% |
| Rock Springs Capital Management LP | 598,000 | $8,324,000 | 0.30% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 136,029 | $1,894,000 | 0.14% |
| FOX RUN MANAGEMENT, L.L.C. | 20,935 | $291,000 | 0.13% |
| Hilltop Holdings Inc. | 39,824 | $554,000 | 0.12% |
| WEXFORD CAPITAL LP | 112,700 | $1,569,000 | 0.10% |
| OXFORD ASSET MANAGEMENT LLP | 296,339 | $4,132,000 | 0.09% |
| Vident Investment Advisory, LLC | 133,272 | $1,855,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 90,000 | $1,253,000 | 0.06% |